PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 17157521

Bone engineering with adipose tissue derived stromal cells.

Konstanze Weinzierl·Alexander Hemprich·Bernhard Frerich
View original source ↗Export metadata ↓

Abstract

INTRODUCTION: Tissue engineering offers the means for replacing or repairing diseased or damaged organs within the patient's body. This current study deals with the general differentiation potential of human adipose tissue derived stromal cells (ATSCs) into mesenchymal tissues and particularly into bone. MATERIAL AND METHODS: ATSCs were isolated and cultivated until the 3rd passage. Three different ways of mesenchymal differentiation (adipogenic, osteogenic, myogenic) were induced and analysed histologically (v. Kossa, Sudan III) and immunhistologically (alpha-actin, osteocalcin). Nine different cell cultures were analysed in terms of calcium deposition (donor's age dependend) in the cell matrix and release of alkaline phosphatase (AP) during the differentiation period. Three-dimensional osteogenic constructs, based on collagenous micro-particles were performed and analysed histologically. RESULTS: Effective differentiation of ATSCs into osteogenic, adipogenic and myogenic cells could be demonstrated in histological and immunohistological analyses. There was an increase of calcium deposition in the cell matrix of osteogenically differentiated ATSCs that did not show any correlation with the age of the donor. Two out of three three-dimensional constructs showed clear zones of mineralization (v. Kossa) in the area of osteocalcin-producing cells. CONCLUSION: Adipose tissue derived stromal cells are a promising source for tissue engineering with a clear potential to differentiate into adipogenic, osteogenic and myogenic cells. The osteogenic differentiation potential did not show any correlation to the age of the donors (calcium deposition, AP-activity). Three-dimensional osteogenic constructs could be established.

Explore related subjects

AdipogenesisAdipose TissueAdolescentAdultAge FactorsAgedCalcification, PhysiologicCell Culture TechniquesCell DifferentiationCells, CulturedChildFemaleHumansMaleMesenchymal Stem CellsMiddle AgedMuscle DevelopmentOsteogenesisStromal CellsTissue EngineeringJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Konstanze Weinzierl, Alexander Hemprich, Bernhard Frerich. 2006-12-08. Bone engineering with adipose tissue derived stromal cells.. https://doi.org/10.1016/j.jcms.2006.07.860

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Transmitochondrial pigs reveal causal effects of mitochondrial DNA on backfat thickness via nuclear epigenetic reprogramming.

Mitochondrial DNA (mtDNA) polymorphisms have been associated with production traits in farm animals, including backfat thickness in pigs, yet direct in vivo evidence establishing a causal link between specific mtDNA haplotypes and fat deposition remains limited. In this study, we generated transmitochondrial pigs (mitopigs) by combining the Dapulian nuclear genome with Wuzhishan mtDNA via somatic cell nuclear transfer, introducing 23 mtDNA mutations relative to controls. Mitopigs exhibited significantly increased backfat thickness at 5 months, a difference that persisted in their offspring, without significant differences in body weight, body size, or litter size. Fibroblasts derived from mitopigs exhibited reduced mtDNA copy numbers, decreased expression of mitochondrial biogenesis genes (PPARA, PPARGC1A, RRM2B, and LRPPRC), impaired mitochondrial respiration, elevated reactive oxygen species (ROS), and upregulated adipogenic transcription factors (CEBPA, CEBPB, and PPARG). Consistent with these fibroblast findings, backfat tissue of mitopigs showed corresponding upregulation of adipogenic transcription factors and downregulation of mitochondrial biogenesis genes. Integrated transcriptomic and whole-genome bisulfite sequencing (WGBS) analyses revealed nuclear transcriptional reprogramming that was closely associated with differential DNA methylation, predominantly affecting mitochondrial function and lipid metabolism pathways. Mitopig fibroblasts also showed a pro-inflammatory response to lipopolysaccharide stimulation, with elevated expression of IL-12, NOS2, RELA, and TNF-α. Our findings provide direct in vivo evidence that mtDNA variants regulate adiposity in pigs through mitochondrial dysfunction, oxidative stress, and nuclear epigenetic modulation, highlighting the potential for incorporating mtDNA haplotype information into pig breeding programs as a complementary strategy to nuclear genomic selection.

Adipogenesis↗
PubMed2007

Oncostatin M promotes osteogenesis and suppresses adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells.

Oncostatin M (OSM) is a multifunctional cytokine of the interleukin-6 family and has been implicated in embryonic development, differentiation, inflammation, and regeneration of liver and bone. In the present study, we demonstrated that treatment of human adipose mesenchymal stem cells (hADSCs) with OSM-attenuated adipogenic differentiation, as indicated by decreased accumulation of intracellular lipid droplets and down-regulated expression of adipocytic markers, such as lipoprotein lipase and PPARgamma. However, OSM treatment stimulated osteogenic differentiation, as demonstrated by the increase in matrix mineralization and expression levels of osteogenic differentiation markers, including alkaline phosphatase, Runx2, and osteocalcin. OSM treatment induced activation of JAK2, JAK3, and ERK in hADSCs, and pre-treatment of hADSCs with the JAK2 inhibitor, AG490, significantly restored the OSM-induced inhibition of adipogenic differentiation. Whereas, the JAK3 inhibitor, WHI-P131, and the MEK inhibitor, U0126, had no effects on the anti-adipogenic activity of OSM. On the other hand, the pro-osteogenic activity of OSM was prevented by treatment of the cells with WHI-P131 or U0126, but not with AG490. These results indicate that distinct signaling pathways, including JAK2, JAK3, and MEK-ERK, play specific roles in the OSM-induced anti-adipogenic and pro-osteogenic differentiation of hADSCs.

Adipogenesis↗
PubMed2006

Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice.

Recent evidence has been presented that expression of lipogenic genes is downregulated in adipose tissue of ob/ob mice as well as in human obesity, suggesting a functionally lipoatrophic state. Using (2)H(2)O labeling, we measured three adipose tissue biosynthetic processes concurrently: triglyceride (TG) synthesis, palmitate de novo lipogenesis (DNL), and cell proliferation (adipogenesis). To determine the effect of the ob/ob mutation (leptin deficiency) on these parameters, adipose dynamics were compared in ob/ob, leptin-treated ob/ob, food-restricted ob/ob, and lean control mice. Adipose tissue fluxes for TG synthesis, de novo lipogenesis (DNL), and adipogenesis were dramatically increased in ob/ob mice compared with lean controls. Low-dose leptin treatment (2 microg/day) via miniosmotic pump suppressed all fluxes to control levels or below. Food restriction in ob/ob mice only modestly reduced DNL, with no change in TG synthesis or adipogenesis. Measurement of mRNA levels in age-matched ob/ob mice showed generally normal expression levels for most of the selected lipid anabolic genes, and leptin treatment had, with few exceptions, only modest effects on their expression. We conclude that leptin deficiency per se results in marked elevations in flux through diverse lipid anabolic pathways in adipose tissue (DNL, TG synthesis, and cell proliferation), independent of food intake, but that gene expression fails to reflect these changes in flux.

Adipogenesis↗